Drug intelligence / Profile preview

NT-202

Development stage
Preclinical
Lead developer
NexThera
Modality
Implantable Hydrogels → Hydrogel Systems → Drug Delivery Systems, Recombinant Proteins and Enzymes, Non-biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems, Biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems, Injectable Hydrogels → Hydrogel Systems → Drug Delivery Systems
01

Overview

NT-202 is a protein polymer-based nanostructure drug candidate being developed by NexThera for the treatment of thrombocytopenia, including idiopathic thrombocytopenic purpura. It is classified as both a polymer and a protein drug. The precise mechanism of action has not been defined or disclosed publicly. As of the latest updates, it remains in preclinical or early research stages with no orphan drug designation and is considered a new molecular entity[1][2].

Brand names
NT-202NT202NT 202
Other names
NT 202NT202NT-202

Beyond the preview

Go deeper on NT-202.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on NT-202.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call